Carregant...
Have we pushed the needle for treatment of Type 1 diabetes?
Studies with immunologics have shown that the natural history of Type 1 diabetes can be modified. These studies have targeted key mediators of the disease and recent analyses, together with studies in preclinical models have identified mechanisms that may be involved in the clinical effects. Several...
Guardat en:
| Publicat a: | Curr Opin Immunol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5937133/ https://ncbi.nlm.nih.gov/pubmed/28992525 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coi.2017.09.004 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|